192 related articles for article (PubMed ID: 26788194)
1. Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.
Huang J; Shi Y; Li H; Tan D; Yang M; Wu X
Oncol Lett; 2015 Dec; 10(6):3705-3711. PubMed ID: 26788194
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2015 Oct; 34(4):2195-201. PubMed ID: 26259653
[TBL] [Abstract][Full Text] [Related]
3. ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.
Yan L; Du Q; Yao J; Liu R
Exp Ther Med; 2016 Dec; 12(6):4128-4134. PubMed ID: 28101190
[TBL] [Abstract][Full Text] [Related]
4. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
5. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
6. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.
Morioka K; Tanikawa C; Ochi K; Daigo Y; Katagiri T; Kawano H; Kawaguchi H; Myoui A; Yoshikawa H; Naka N; Araki N; Kudawara I; Ieguchi M; Nakamura K; Nakamura Y; Matsuda K
Cancer Sci; 2009 Jul; 100(7):1227-33. PubMed ID: 19486338
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic role of REG γ is exerted by activating the Wnt/β-catenin signaling pathway in osteosarcoma.
Yin Z; Peng Z; Wang Z; Meng Q
Am J Transl Res; 2020; 12(2):563-573. PubMed ID: 32194904
[TBL] [Abstract][Full Text] [Related]
8. Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.
Wang Q; Liu H; Wang Q; Zhou F; Liu Y; Zhang Y; Ding H; Yuan M; Li F; Chen Y
PLoS One; 2017; 12(6):e0180558. PubMed ID: 28665975
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2.
Jiang Z; Jiang C; Yu C; Fang J
Tumour Biol; 2017 Jun; 39(6):1010428317705751. PubMed ID: 28618961
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration.
van Zuylen WJ; Ford CE; Wong DD; Rawlinson WD
J Virol; 2016 Jan; 90(2):1108-15. PubMed ID: 26559837
[TBL] [Abstract][Full Text] [Related]
12. DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression.
Chen Y; Wang Q; Wang Q; Liu J; Jiang X; Zhang Y; Liu Y; Zhou F; Liu H
Front Pharmacol; 2018; 9():1558. PubMed ID: 30733679
[TBL] [Abstract][Full Text] [Related]
13. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.
Tang L; Wang D; Gu D
Pathol Oncol Res; 2018 Oct; 24(4):907-913. PubMed ID: 29619662
[TBL] [Abstract][Full Text] [Related]
15. Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells.
Yu Y; Li Y; Zhou L; Yang G; Wang M; Hong Y
Med Sci Monit; 2018 Jun; 24():3856-3862. PubMed ID: 29879092
[TBL] [Abstract][Full Text] [Related]
16. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
17. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
[TBL] [Abstract][Full Text] [Related]
18. ROR2 deficit may induce the tetralogy of Fallot via down-regulating of β-catenin/SOX3/HSPA6 in vitro and in vivo.
Guo R; Guo YZ; Zhou Q; Li G; Du Z; Shi Y; Xing Q
J Cell Mol Med; 2023 Nov; 27(22):3539-3552. PubMed ID: 37749917
[TBL] [Abstract][Full Text] [Related]
19. miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3.
Zhao G; Zhang L; Qian D; Sun Y; Liu W
Onco Targets Ther; 2019; 12():6133-6143. PubMed ID: 31447563
[No Abstract] [Full Text] [Related]
20. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
